Clinical trial
An Open-Label Pilot Study of Creatine for Depressed Male and Female Methamphetamine Users
NCT02568878 is registered in ClinicalTrials.gov with Montana State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Pilot Study of Creatine for Depressed Male and Female Methamphetamine Users
- Lead sponsor
- Montana State University
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- November 30, 2015
- Completion date
- May 31, 2017
- Enrollment
- 29 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anxiety, depression, methamphetamine dependence